Agios Delivers Q1 2026 Financial Results & Business Update
Agios reported a sharp step-up in Q1 2026 performance on the back of its U.S. launch of Aqvesme (mitapivat)...
eClinical Tech News
Teva to Acquire Emalex, Adds NDA-Ready Neuroscience Drug
Teva Pharmaceuticals has signed a definitive agreement to acquire Emalex Biosciences for $700 million upfront, with up to $200...
Study Reveals Under-recognised Genetic Driver for Adult FSGS
Purespring Therapeutics has published a population modeling study in Kidney International Reports indicating that pathogenic NPHS2 variants are a...
Plus Therapeutics Secures Blue Shield Coverage for CNSide Assay
CNSide Diagnostics, a subsidiary of Plus Therapeutics, secured payer coverage from Blue Shield of California for its CNSide Cerebrospinal...
Novartis Q1 Growth Surges; 2026 Forecast Reaffirmed
Novartis opened 2026 with a mixed first quarter: net sales declined 5% at constant currency and core operating income...
Siren Biotech Publishes Foundational AAV Immuno-Gene Data
Siren Biotechnology has published its first peer-reviewed data in Molecular Therapy Oncology on a universal AAV immuno-gene therapy platform...
Exparel Data: Breakthrough in Lowering Opioid Use & Costs
Pacira BioSciences reported new real-world evidence showing its long-acting local anesthetic, EXPAREL (bupivacaine liposome injectable suspension), was associated with...
Arcutis Submits Zoryve sNDA to FDA for Infants, Babies
Arcutis has filed a supplemental NDA with the FDA to extend ZORYVE (roflumilast) cream 0.05% to infants aged 3...
Dark Horse & Porton Advanced Streamline IITs in China
Dark Horse Consulting Group and Porton Advanced have signed a memorandum of understanding to create an integrated pathway for...
Codexis Announcing First Quarter 2026 Financial Results
Codexis will report first-quarter 2026 results on May 7 after market close, with a management call to follow. For...